1-3 of 3
David Kuo
Close
Sort by
Journal Articles

Harnessing Artificial Intelligence for Risk Stratification in Acute Myeloid Leukemia (AML): Evaluating the Utility of Longitudinal Electronic Health Record (EHR) Data Via Graph Neural Networks

Riya Sinha, Matthew Schwede, Ben Viggiano, David Kuo, Solomon Henry, Douglas Wood, Gabriel Mannis, Ravindra Majeti, Jonathan Chen, Tian Y. Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 960.
https://doi.org/10.1182/blood-2023-190151
Published: 2023
Journal Articles

Multiplexed Immunofluorescence (IF) Analysis and Gene Expression Profiling of Biopsies from Patients with Relapsed/Refractory (R/R) Diffuse Large B Cell Lymphoma (DLBCL) Treated with Lisocabtagene Maraleucel (liso-cel) in Transcend NHL 001 Reveal Patterns of Immune Infiltration Associated with Durable Response

David J. Reiss, PhD, Trevor Do, David Kuo, Vanessa E. Gray, N. Eric Olson, Chung-Wein Lee, Mary H. Young, PhD, Shradha Srinivasan, Falon D. Gray, DVM, DACVP, Brian Fox, Suzana Couto, Jason A. Dubovsky, PhD, Frank Schmitz, Kathryn Newhall
Journal: Blood
Blood (2019) 134 (Supplement_1): 202.
https://doi.org/10.1182/blood-2019-127683
Published: 2019
Journal Articles

Validation Study of Logistic Regression in Classifying Primary Vitreoretinal Lymphoma Vs. Uveitis By IL-6 and IL-10 Levels

David Kuo, MD, Maggie Wei, MD, Jared Knickelbein, MD PhD, Karen Armbrust, MD PhD, Ian Yeung, MD, Chi-Chao Chan, MD, Nida Sen, MD MHS
Journal: Blood
Blood (2018) 132 (Supplement 1): 2971.
https://doi.org/10.1182/blood-2018-99-114199
Published: 2018